It may be possible to predict diagnostic transition to schizophrenia and bipolar disorder from machine learning models.

Individuals with generalized anxiety disorder (GAD), a condition characterized by daily excessive worry lasting at least six ...

Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced the launch of the aPAP ClearPath Dried Blood Spot (DBS) Test in the U.S., an ...

Individuals with generalized anxiety disorder (GAD), a condition characterized by daily excessive worry lasting at least six ...

According to WHO, cognitive health, in particular, is the ability to think, learn, and remember and is crucial for ...

Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, ...

Genomenon, a leader in genomic intelligence, today announced the launch of an enhanced AI-powered integration for its Mastermind Genomic Intelligence Platform. This new capability further refines ...

CRISPR technology offers innovative solutions for pandemic preparedness, enhancing diagnostics, antiviral therapies, and ...

A smartwatch algorithm detects cardiac arrest early—could this AI-powered tech save lives? Read the latest research now.

Clinical Validation and Performance Assessment of a Urinary Biomarker Within the Surveillance of Patients With ...

A key trend shaping the market is the adoption of automated COVID-19 testing systems, allowing laboratories and healthcare ...